Serum thioredoxin activity: a promising biomarker for assessment of coronary stenosis severity in patients with coronary artery disease
基本信息来源于合作网站,原文需代理用户跳转至来源网站获取
摘要:
Coronary artery disease (CAD) is one of the major death causes worldwide.Therapeutic methods may improve the progress of CAD.Thus,specific biomarkers are required for detecting coronary stenosis severity and monitoring therapy.Although spiral computed tomography (CT) angiography or coronary angiography may accurate detect coronary stenosis,the both techniques are expensive and not used as a "screening" test in the general population.The diagnostic ability of coronary angiography decreased in severe and complex lesions,especially for distal segments [1].The diagnostic value of Coronary CT angiography is hampered by certain limitations [2].Therefore,there is need for more convenient methods to predict coronary stenosis severity.